Andrew Lo - 29 Dec 2021 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Yi Ching Yau, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
29 Dec 2021
Net transactions value
+$98,850
Form type
4
Filing time
03 Jan 2022, 18:57:06 UTC
Previous filing
07 Dec 2021
Next filing
24 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Purchase $77,400 +6,000 +15% $12.90 46,599 29 Dec 2021 Direct
transaction BBIO Common Stock Purchase $21,450 +1,500 +3.2% $14.30 48,099 30 Dec 2021 Direct
holding BBIO Common Stock 205,583 29 Dec 2021 By Andrew W. Lo and Nancy N. Lo JTWROS
* An asterisk sign (*) next to the price indicates that the price is likely invalid.